- Home
- KRRO vs NUW Comparison
KRRO vs NUW Comparison
Compare KRRO & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- NUW
- Stock Information
- Founded
- KRRO 2014
- NUW 2008
- Country
- KRRO United States
- NUW United States
- Employees
- KRRO N/A
- NUW N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- NUW Investment Managers
- Sector
- KRRO Health Care
- NUW Finance
- Exchange
- KRRO Nasdaq
- NUW Nasdaq
- Market Cap
- KRRO 209.6M
- NUW N/A
- IPO Year
- KRRO 2019
- NUW N/A
- Fundamental
- Price
- KRRO $16.68
- NUW $13.83
- Analyst Decision
- KRRO Strong Buy
- NUW
- Analyst Count
- KRRO 7
- NUW 0
- Target Price
- KRRO $132.17
- NUW N/A
- AVG Volume (30 Days)
- KRRO 92.3K
- NUW 45.3K
- Earning Date
- KRRO 03-18-2025
- NUW 01-01-0001
- Dividend Yield
- KRRO N/A
- NUW 3.66%
- EPS Growth
- KRRO N/A
- NUW N/A
- EPS
- KRRO N/A
- NUW N/A
- Revenue
- KRRO $2,271,000.00
- NUW N/A
- Revenue This Year
- KRRO N/A
- NUW N/A
- Revenue Next Year
- KRRO N/A
- NUW N/A
- P/E Ratio
- KRRO N/A
- NUW N/A
- Revenue Growth
- KRRO N/A
- NUW N/A
- 52 Week Low
- KRRO $15.21
- NUW $12.45
- 52 Week High
- KRRO $98.00
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- KRRO 28.61
- NUW 53.49
- Support Level
- KRRO $15.16
- NUW $13.74
- Resistance Level
- KRRO $25.25
- NUW $14.06
- Average True Range (ATR)
- KRRO 2.80
- NUW 0.12
- MACD
- KRRO -0.30
- NUW 0.00
- Stochastic Oscillator
- KRRO 9.60
- NUW 66.67
Stock Price Comparison Chart: KRRO vs NUW
■ KRRO
■ NUW
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Share on Social Networks:
0